Abstract
1. Intrathecal (i.t.) administration of prostaglandin E2 (PGE2) to conscious mice was reported to induce allodynia, a state of discomfort and pain evoked by innocuous tactile stimuli through prostaglandin E receptor subtype EP1 and hyperalgesia through prostaglandin E receptor subtypes EP2 and/or EP3. In the present study, we investigated the effects of an EP1 antagonist on these sensory disorders by use of ONO-NT-012 or AH6809. 2. ONO-NT-012 dose-dependently antagonized the PGE2-induced allodynia but had no effect on the PGE2-induced hyperalgesia by the hot plate test. On the other hand, AH6809 blocked the PGE2-induced hyperalgesia at the highest dose examined (50 micrograms kg-1) but had no effect on the PGE2-induced allodynia. The i.t. injection of AH6809 or ONO-NT-012 alone did not have any effect on the response to noxious or innocuous stimuli. 3. Increasing doses (5 pg kg(-1)-500 ng kg-1) of ONO-NT-012 produced parallel shifts to the right of the dose-response curves to PGE2. The Schild plot regression line was linear and the slope was close to unity. The pA2 value against PGE2 was calculated to be 9.96. 4. The present study demonstrates that i.t. administration of PGE2 exerts allodynia through EP1 in the mouse spinal cord and that ONO-NT-012 is a highly potent, simple competitive antagonist for the PGE2-induced allodynia.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hylden J. L., Wilcox G. L. Intrathecal morphine in mice: a new technique. Eur J Pharmacol. 1980 Oct 17;67(2-3):313–316. doi: 10.1016/0014-2999(80)90515-4. [DOI] [PubMed] [Google Scholar]
- Ito S., Okuda E., Sugama K., Negishi M., Hayaishi O. Evaluation of ZK110841 and AH6809, an agonist and an antagonist of prostaglandin DP-receptors on human platelets, with a PGD2-responsive cell line from bovine embryonic trachea. Br J Pharmacol. 1990 Jan;99(1):13–14. doi: 10.1111/j.1476-5381.1990.tb14645.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keery R. J., Lumley P. AH6809, a prostaglandin DP-receptor blocking drug on human platelets. Br J Pharmacol. 1988 Jul;94(3):745–754. doi: 10.1111/j.1476-5381.1988.tb11584.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Minami T., Nishihara I., Uda R., Ito S., Hyodo M., Hayaishi O. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice. Br J Pharmacol. 1994 Jul;112(3):735–740. doi: 10.1111/j.1476-5381.1994.tb13139.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Minami T., Nishihara I., Uda R., Ito S., Hyodo M., Hayaishi O. Involvement of glutamate receptors in allodynia induced by prostaglandins E2 and F2 alpha injected into conscious mice. Pain. 1994 May;57(2):225–231. doi: 10.1016/0304-3959(94)90227-5. [DOI] [PubMed] [Google Scholar]
- Minami T., Uda R., Horiguchi S., Ito S., Hyodo M., Hayaishi O. Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice. Pain. 1994 May;57(2):217–223. doi: 10.1016/0304-3959(94)90226-7. [DOI] [PubMed] [Google Scholar]
- Uda R., Horiguchi S., Ito S., Hyodo M., Hayaishi O. Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice. Brain Res. 1990 Feb 26;510(1):26–32. doi: 10.1016/0006-8993(90)90723-o. [DOI] [PubMed] [Google Scholar]
- Yaksh T. L., Harty G. J. Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. J Pharmacol Exp Ther. 1988 Feb;244(2):501–507. [PubMed] [Google Scholar]
- Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983 Jun;16(2):109–110. doi: 10.1016/0304-3959(83)90201-4. [DOI] [PubMed] [Google Scholar]